Daniel Gaudet

27PUBLICATIONS

82CO-AUTHORS

EndodonticsProteins and peptidesEpigenetics (incl. genome methylation and epigenomics)Molecular targetsHaematology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (27)

Sort by Publication Date:

|Jun 04, 2026

New and Emerging Therapeutic Targets for ApoB-Containing Particles Lowering.

|May 26, 2026

In Vivo Base Editing of <i>PCSK9</i> with VERVE-102 for Hypercholesterolemia.

|Apr 07, 2026

Zodasiran for cholesterol and triglyceride lowering in patients with hyperlipidemia: final report of phase 1 basket trial.

Gerald F Watts, Russell Scott, David Sullivan

|Mar 30, 2026

Effect of APOC3 Inhibition With Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study.

Nicholas A Marston, Brian A Bergmark, Thomas A Prohaska

|Mar 27, 2026

Evinacumab with or without lipoprotein apheresis in homozygous familial hypercholesterolaemia.

Patrick M Moriarty, Albert Wiegman, Richard Godin

|Mar 25, 2026

ApoC-III inhibition: from regulatory approval to equitable implementation.

Daniel Gaudet, Miriam Larouche, Erik S G Stroes

Pageof 5

Frequent Collaborators

Miriam Larouche

Albert Wiegman

Robert A Hegele

Robert Pordy

Erik S G Stroes

Frederick J Raal

Etienne Khoury

Alberico L Catapano

Raul D Santos

Veronica J Alexander

Frequent Collaborators

Miriam Larouche

Albert Wiegman

Robert A Hegele

Robert Pordy